Article
Effect of the calcimimetic R-568 [3-(2-chlorophenyl)-N-((1R)-1-(3-methoxyphenyl)ethyl)-1-propanamine] on correcting inactivating mutations in the human calcium-sensing receptor.
The Journal of pharmacology and experimental therapeutics - 1 Dec 2009
Lu Jenny Ying Lin, Yang Yuhua, Gnacadja Gilles, Christopoulos Arthur, Reagan Jeff D
Abstract excerpt
Over 257 mutations in the human calcium-sensing receptor (hCaSR) gene have been reported. Heterozygous inactivating mutations can result in familial hypocalciuric hypercalcemia (FHH), whereas homozygous inactivating mutations can cause life-threatening neonatal severe hyperparathyroidism (NSHPT). Activating mutations in the hCaSR can result in hypercalciuria and hypocalcemia. A recent publication on the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.